Newly-launched biotech venture, PHIOGEN, received an enthusiastic reception at the 6th World Conference on Targeting Phage Therapy, where it was recognized by organizers with the ‘Best Scientific Innovation Award’. The company, which is a spin-off from Baylor College of Medicine and was born out of innovation from the team at TAILOR Labs, made its debut…
Ambitious new biotech venture PHIOGEN has developed a world-first technology platform that mobilizes the natural power of bacteriophages to tackle critical and life-threatening infections, marking a significant medical breakthrough for countering the global threat of antimicrobial resistance. The company will make its debut at the 6th World Congress on Targeting Phage Therapy in Paris, June…
